Reporting Quality of Randomized Controlled Trials for the Treatment of Eczema with Chinese Patent Medicine Based on the CONSORT-CHM Formulas 2017
Table 5
Univariable analysis of reporting rate of each item of the CONSORT-CHM formulas 2017.
Item number
Year of publication
OR (95% CI)
value
Type of the first author’s hospital
OR (95% CI)
value
≥2015
<2015
University hospital
Nonuniversity hospital
1a
2/50 (4%)
2/94 (2.13%)
1.92 (0.26–14.03)
0.906
3/73 (4.11%)
1/71 (1.41%)
3.00 (0.31–29.55)
0.632
1b
44/50 (88%)
56/94 (59.57%)
4.98 (1.93–12.83)
<0.001
45/73 (61.64%)
55/71 (77.46%)
0.47 (0.23–0.97)
0.039
1c
4/50 (8%)
1/94 (1.06%)
8.09 (0.88–74.43)
0.092
4/73 (5.48%)
1/71 (1.41%)
4.06 (0.44–37.23)
0.379
2a
46/50 (92%)
53/94 (56.38%)
8.90 (2.96–26.73)
<0.001
53/73 (72.60%)
46/71 (64.79%)
1.44 (0.71–2.92)
0.312
2b
19/50 (38%)
16/94 (17.02%)
2.99 (1.36–6.55)
0.005
24/73 (32.88%)
11/71(15.49%)
2.67 (1.19–5.99)
0.015
3a
50/50 (100%)
92/94 (97.87%)
NE
0.544
71/73 (97.26%)
71/71 (100%)
NE
0.497
3b
0/0 (0%)
0/0 (0%)
NE
NE
0/0 (0%)
0/0 (0%)
NE
NE
4a
32/50 (64%)
50/94 (53.19%)
1.56 (0.77–3.17)
0.212
44/73 (60.27%)
38/71 (53.52%)
1.32 (0.68–2.55)
0.413
4b
46/50 (92%)
77/94 (81.91%)
2.54 (0.81–8.01)
0.103
65/73 (89.04%)
58/71 (81.69%)
1.82 (0.71–4.71)
0.211
5
39/50 (78%)
75/94 (79.79%)
0.90 (0.39–2.08)
0.801
62/73 (84.93%)
52/71 (73.24%)
2.06 (0.90–4.72)
0.084
6a
33/50 (66%)
73/94(77.66%)
0.56 (0.26–1.19)
0.131
58/73 (79.45%)
48/71 (67.61%)
1.85 (0.87–3.94)
0.107
6b
0/0 (0%)
0/0 (0%)
NE
NE
0/0 (0%)
0/0 (0%)
NE
NE
7a
1/50 (2%)
0/94 (0%)
NE
0.347
1/73 (1.37%)
0/71 (0%)
NE
1.000
7b
0/0 (0%)
0/0 (0%)
NE
NE
0/0 (0%)
0/0 (0%)
NE
NE
8a
17/50 (34%)
17/94 (18.09%)
2.33 (1.06–5.12)
0.032
21/73 (28.77%)
13/71 (18.31%)
1.80 (0.82–3.96)
0.140
8b
2/50 (4%)
2/94 (2.13%)
1.92 (0.26–14.03)
0.906
4/73 (5.48%)
0/71 (0%)
NE
0.135
9
1/50 (2%)
0/94 (0%)
NE
0.347
1/73 (1.37%)
0/71 (0%)
NE
1.000
10
1/50 (2%)
0/94(0%)
NE
0.347
1/73 (1.37%)
0/71(0%)
NE
1.000
11a
1/50 (2%)
4/94 (4.26%)
0.46 (0.05–4.22)
0.821
5/73 (6.85%)
0/71 (0%)
NE
0.074
11b
1/1 (100%)
2/5 (40%)
NE
1.000
3/6 (50%)
0/0 (0%)
NE
NE
12a
46/50 (92%)
69/94 (73.40%)
4.17 (1.36–12.76)
0.008
60/73 (82.19%)
55/71 (77.46%)
1.34 (0.59–3.04)
0.479
12b
2/2 (100%)
2/4 (50%)
NE
0.467
2/3 (66.67%)
2/3(66.67%)
1.00 (0.03–29.81)
1.000
13a
50/50 (100%)
94/94 (100%)
NE
NE
73/73 (100%)
71/71 (100%)
NE
NE
13b
48/50 (96%)
89/94 (94.68%)
1.35 (0.25–7.21)
1.000
70/73 (95.89%)
67/71 (94.37%)
1.39 (0.30–6.46)
0.970
14a
46/50 (92%)
73/94 (77.66%)
3.31 (1.07–10.25)
0.031
67/73 (91.78%)
52/71 (73.24%)
4.08 (1.52–10.95)
0.003
14b
0/0 (0%)
0/0 (0%)
NE
NE
0/0 (0%)
0/0 (0%)
NE
NE
15
3/50 (6%)
5/94 (5.32%)
1.14 (0.26–4.96)
1.000
8/73 (10.96%)
0/71 (0%)
NE
0.012
16
50/50 (100%)
94/94 (100%)
NE
NE
73/73 (100%)
71/71 (100%)
NE
NE
17a
0/50 (0%)
0/94 (0%)
NE
NE
0/73 (0%)
0/71 (0%)
NE
NE
17b
0/50 (0%)
0/93 (0%)
NE
NE
0/72 (0%)
0/71 (0%)
NE
NE
18
2/2 (100%)
4/4 (100%)
NE
NE
3/3 (100%)
3/3 (100%)
NE
NE
19
44/50 (88%)
76/94 (80.85%)
1.74 (0.64–4.70)
0.273
60/73 (82.19%)
60/71 (84.51%)
0.85 (0.35–2.04)
0.709
20
6/50 (12%)
2/94 (2.13%)
6.27 (1.22–32.34)
0.038
5/73 (6.85%)
3/71 (4.23%)
1.67 (0.38–7.25)
0.746
21
29/50 (58%)
45/94 (47.87%)
1.50 (0.75–3.01)
0.247
35/73 (47.95%)
39/71 (54.93%)
0.76 (0.39–1.46)
0.402
22
45/50 (90%)
73/94 (77.66%)
2.59 (0.91–7.35)
0.067
58/73 (79.45%)
60/71 (84.51%)
0.71 (0.30–1.67)
0.430
23
1/50 (2%)
0/94 (0%)
NE
0.347
1/73 (1.37%)
0/71 (0%)
NE
1.000
24
2/50 (4%)
0/94 (0%)
NE
0.119
2/73 (2.74%)
0/71 (0%)
NE
0.497
25
6/50 (12%)
3/94 (3.19%)
4.14 (0.99–17.32)
0.086
9/73 (12.33%)
0/71 (0%)
NE
0.007
CONSORT-CHM formulas, Consolidated Standards of Reporting Trials for Chinese herbal medicine formulas; CI, confidence interval; OR, odds ratio; NE, not estimable.